{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T22:57:52Z","timestamp":1775861872533,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,20]]},"DOI":"10.7759\/cureus.80880","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T13:17:19Z","timestamp":1742476639000},"source":"Crossref","is-referenced-by-count":1,"title":["Polymyalgia Rheumatica and Giant Cell Arteritis: A Geriatric Perspective"],"prefix":"10.7759","author":[{"given":"Ayaz","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia H","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umer","family":"Roohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Elgorashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohail","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayab","family":"Sami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay MA","year":"2009","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009, 61:1454-61. 10.1002\/art.24459","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig AK","year":"2022","unstructured":"Hemmig AK, Gozzoli D, Werlen L, et al.. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. Semin Arthritis Rheum. 2022, 55:152017. 10.1016\/j.semarthrit.2022.152017","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14288","article-title":"The diagnostic accuracy of temporal artery ultrasound and temporal artery biopsy in giant cell arteritis: a single center Australian experience over 10\u00a0years","volume":"25","author":"He J","year":"2022","unstructured":"He J, Williamson L, Ng B, et al.. The diagnostic accuracy of temporal artery ultrasound and temporal artery biopsy in giant cell arteritis: a single center Australian experience over 10\u00a0years. Int J Rheum Dis. 2022, 25:447-53. 10.1111\/1756-185X.14288","journal-title":"Int J Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit F","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016, 315:2442-58. 10.1001\/jama.2016.5444","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10155","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"324","author":"Buttgereit F","year":"2020","unstructured":"Buttgereit F, Matteson EL, Dejaco C. Polymyalgia rheumatica and giant cell arteritis. JAMA. 2020, 324:993-4. 10.1001\/jama.2020.10155","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308514","article-title":"Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases","volume":"102","author":"Pujades-Rodriguez M","year":"2016","unstructured":"Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Smeeth L, Hemingway H. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases. Heart. 2016, 102:383-9. 10.1136\/heartjnl-2015-308514","journal-title":"Heart"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.009","article-title":"Glucocorticoids for management of polymyalgia rheumatica and giant cell arteritis","volume":"42","author":"Matteson EL","year":"2016","unstructured":"Matteson EL, Buttgereit F, Dejaco C, Dasgupta B. Glucocorticoids for management of polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am. 2016, 42:75-90. 10.1016\/j.rdc.2015.08.009","journal-title":"Rheum Dis Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0987-1","article-title":"Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study","volume":"16","author":"Paskins Z","year":"2018","unstructured":"Paskins Z, Whittle R, Sultan AA, et al.. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med. 2018, 16:4. 10.1186\/s12916-017-0987-1","journal-title":"BMC Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103589","article-title":"Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: a systematic literature review highlighting differences from the idiopathic forms","volume":"23","author":"Hysa E","year":"2024","unstructured":"Hysa E, Casabella A, Gotelli E, et al.. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: a systematic literature review highlighting differences from the idiopathic forms. Autoimmun Rev. 2024, 23:103589. 10.1016\/j.autrev.2024.103589","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew273","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco C","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017, 56:506-15. 10.1093\/rheumatology\/kew273","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.05.023","article-title":"A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis","volume":"50","author":"Hysa E","year":"2020","unstructured":"Hysa E, Sobrero A, Camellino D, et al.. A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis. Semin Arthritis Rheum. 2020, 50:1131-9. 10.1016\/j.semarthrit.2020.05.023","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103590","article-title":"The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: a systematic review of clinical trials","volume":"23","author":"Kawka L","year":"2024","unstructured":"Kawka L, Chevet B, Arnaud L, Becker G, Carvajal Alegria G, Felten R. The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: a systematic review of clinical trials. Autoimmun Rev. 2024, 23:103590. 10.1016\/j.autrev.2024.103590","journal-title":"Autoimmun Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11163","article-title":"The utility of 18F-FDG PET\/CT in patients with clinical suspicion of polymyalgia rheumatica and giant cell arteritis: a prospective, observational, and cross-sectional study","volume":"2","author":"Emamifar A","year":"2020","unstructured":"Emamifar A, Ellingsen T, Hess S, et al.. The utility of 18F-FDG PET\/CT in patients with clinical suspicion of polymyalgia rheumatica and giant cell arteritis: a prospective, observational, and cross-sectional study. ACR Open Rheumatol. 2020, 2:478-90. 10.1002\/acr2.11163","journal-title":"ACR Open Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma A","year":"2020","unstructured":"Sharma A, Mohammad AJ, Turesson C. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum. 2020, 50:1040-8. 10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21750","article-title":"Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica","volume":"64","author":"Unizony S","year":"2012","unstructured":"Unizony S, Arias-Urdaneta L, Miloslavsky E, et al.. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken). 2012, 64:1720-9. 10.1002\/acr.21750","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead471","article-title":"Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review","volume":"63","author":"Hysa E","year":"2024","unstructured":"Hysa E, Bond M, Ehlers L, et al.. Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review. Rheumatology (Oxford). 2024, 63:285-97. 10.1093\/rheumatology\/kead471","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.004","article-title":"New insights into the pathogenesis of giant cell arteritis","volume":"16","author":"Ciccia F","year":"2017","unstructured":"Ciccia F, Rizzo A, Ferrante A, et al.. New insights into the pathogenesis of giant cell arteritis. Autoimmun Rev. 2017, 16:675-83. 10.1016\/j.autrev.2017.05.004","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.04.001","article-title":"Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015","volume":"47","author":"Crowson CS","year":"2017","unstructured":"Crowson CS, Matteson EL. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Semin Arthritis Rheum. 2017, 47:253-6. 10.1016\/j.semarthrit.2017.04.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco C","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, et al.. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018, 77:636-43. 10.1136\/annrheumdis-2017-212649","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000531","article-title":"Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence?","volume":"3","author":"De Smit E","year":"2017","unstructured":"De Smit E, Clarke L, Sanfilippo PG, Merriman TR, Brown MA, Hill CL, Hewitt AW. Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence?. RMD Open. 2017, 3:000531. 10.1136\/rmdopen-2017-000531","journal-title":"RMD Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/ar293","article-title":"Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica","volume":"3","author":"Gonzalez-Gay MA","year":"2001","unstructured":"Gonzalez-Gay MA. Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica. Arthritis Res. 2001, 3:154-7. 10.1186\/ar293","journal-title":"Arthritis Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg IE","year":"2022","unstructured":"Lundberg IE, Sharma A, Turesson C, Mohammad AJ. An update on polymyalgia rheumatica. J Intern Med. 2022, 292:717-32. 10.1111\/joim.13525","journal-title":"J Intern Med"},{"key":"ref23","article-title":"Giant cell arteritis (temporal arteritis)","author":"Ameer MA","year":"2024","unstructured":"Ameer MA, Vaqar S, Khazaeni B. Giant cell arteritis (temporal arteritis). StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.173","article-title":"A typical case of giant cell arteritis with vision loss due to delayed diagnosis","volume":"19","author":"Watanabe A","year":"2018","unstructured":"Watanabe A, Isono H, Shimada K, Chino Y. A typical case of giant cell arteritis with vision loss due to delayed diagnosis. J Gen Fam Med. 2018, 19:139-40. 10.1002\/jgf2.173","journal-title":"J Gen Fam Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003192","article-title":"Normal ESR, CRP and platelet count in giant cell arteritis and polymyalgia rheumatica: a diagnostic conundrum","volume":"9","author":"Mahgoub AE","year":"2022","unstructured":"Mahgoub AE, Tessema S, Nakhleh R. Normal ESR, CRP and platelet count in giant cell arteritis and polymyalgia rheumatica: a diagnostic conundrum. Eur J Case Rep Intern Med. 2022, 9:003192. 10.12890\/2022_003192","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004488","article-title":"Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica","volume":"10","author":"Ramon A","year":"2024","unstructured":"Ramon A, Greigert H, Goueslard K, et al.. Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica. RMD Open. 2024, 10:004488. 10.1136\/rmdopen-2024-004488","journal-title":"RMD Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_3163_22","article-title":"Temporal artery biopsy for suspected giant cell arteritis: a mini review","volume":"71","author":"Jiang Z","year":"2023","unstructured":"Jiang Z, Ji H, Dong J. Temporal artery biopsy for suspected giant cell arteritis: a mini review. Indian J Ophthalmol. 2023, 71:3299-304. 10.4103\/IJO.IJO_3163_22","journal-title":"Indian J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkab059","article-title":"Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis","volume":"5","author":"Sebastian A","year":"2021","unstructured":"Sebastian A, Coath F, Innes S, Jackson J, van der Geest KS, Dasgupta B. Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis. Rheumatol Adv Pract. 2021, 5:059. 10.1093\/rap\/rkab059","journal-title":"Rheumatol Adv Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.908727","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian bone Club","volume":"13","author":"Laurent MR","year":"2022","unstructured":"Laurent MR, Goemaere S, Verroken C, et al.. Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian bone Club. Front Endocrinol (Lausanne). 2022, 13:908727. 10.3389\/fendo.2022.908727","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta A","year":"2013","unstructured":"Gupta A, Gupta Y. Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab. 2013, 17:913-6. 10.4103\/2230-8210.117215","journal-title":"Indian J Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42371-z","article-title":"Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib","volume":"13","author":"Spinelli FR","year":"2023","unstructured":"Spinelli FR, Garufi C, Mancuso S, Ceccarelli F, Truglia S, Conti F. Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib. Sci Rep. 2023, 13:15537. 10.1038\/s41598-023-42371-z","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand CM","year":"2014","unstructured":"Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014, 371:50-7. 10.1056\/NEJMcp1214825","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061588","article-title":"Advances in the treatment of giant cell arteritis","volume":"11","author":"Casta\u00f1eda S","year":"2022","unstructured":"Casta\u00f1eda S, Prieto-Pe\u00f1a D, Vicente-Rabaneda EF, et al.. Advances in the treatment of giant cell arteritis. J Clin Med. 2022, 11:1588. 10.3390\/jcm11061588","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152174","article-title":"Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: a single-centre prospective study","volume":"59","author":"Tomelleri A","year":"2023","unstructured":"Tomelleri A, Campochiaro C, Farina N, et al.. Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: a single-centre prospective study. Semin Arthritis Rheum. 2023, 59:152174. 10.1016\/j.semarthrit.2023.152174","journal-title":"Semin Arthritis Rheum"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000162","article-title":"Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases","volume":"1","author":"Izumi K","year":"2015","unstructured":"Izumi K, Kuda H, Ushikubo M, Kuwana M, Takeuchi T, Oshima H. Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases. RMD Open. 2015, 1:000162. 10.1136\/rmdopen-2015-000162","journal-title":"RMD Open"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/life13122244","article-title":"Examining the safety profile of Janus kinase (JAK) inhibitors in the management of immune-mediated diseases: a comprehensive review","volume":"13","author":"Kraev K","year":"2023","unstructured":"Kraev K, Geneva-Popova MG, Hristov BK, et al.. Examining the safety profile of Janus kinase (JAK) inhibitors in the management of immune-mediated diseases: a comprehensive review. Life (Basel). 2023, 13:2244. 10.3390\/life13122244","journal-title":"Life (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348507-polymyalgia-rheumatica-and-giant-cell-arteritis-a-geriatric-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T13:17:21Z","timestamp":1742476641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348507-polymyalgia-rheumatica-and-giant-cell-arteritis-a-geriatric-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.80880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}